This week’s episode features Dr. John H. Rundback, Director of the Interventional Institute at Holy Name Medical Center and one of the most experienced voices in complex peripheral work. Dr. Rundback joins Miguel and Lucas for a grounded conversation on how below-the-knee disease has changed, why operators rely on different tools and access strategies today, and what the AMBITION BTK clinical trial aims to clarify about treating BTK patients. Along the way, he shares insights shaped by decades of clinical practice, research leadership, and his role in major multicenter studies. This episode follows Dr. John Rundback’s perspective on BTK disease and how new tools and techniques shape everyday decision-making. 03:09 How BTK and below-the-ankle disease differ from proximal disease 05:28 What pushed operators toward atherectomy in BTK care 06:56 Introducing AngioDynamics and the AMBITION BTK trial 10:49 How the Auryon laser works and what makes it different 14:44 Why early results led to launching the AMBITION BTK study 20:06 How high-volume operators identify meaningful patterns early 23:28 Tips and workflow for using the Auryon laser below the knee 29:12 Why Miguel now uses primary pedal access in many BTK cases 37:30 How the AMBITION BTK trial uses a hierarchical win-ratio endpoint Who Should Listen This episode is relevant for clinicians who treat below-the-knee disease, early-career physicians interested in real-world atherectomy decision making, and professionals involved in device evaluation, trial design, and BTK care pathways. About John H. Rundback, MD John H. Rundback, MD, is a renowned interventional radiologist in practice since 1993 and is the Director of the Interventional Institute at Holy Name Medical Center. He is board-certified in radiology and holds a Certificate of Added Qualification in Angiography and Interventional Radiology. He has been named as a Top Doctor by Castle Connolly. Dr. Rundback's research interests include peripheral arterial, carotid, and aortic aneurysmal disease, deep venous thrombosis and varicose veins, as well as state-of-the-art minimally invasive cancer therapies, and he is the principal investigator on a number of multi-center trials. He has presented at more than 200 conferences and is the program chairman for his own peripheral arterial disease symposium. He has served as an editor and reviewer for peer-reviewed medical journals and has published over 100 articles. Dr. Rundback is a past member of the Board of Directors of the Society of Interventional Radiology Foundation and Founding Chair for the Foundation's Cooperative Alliance for Interventional Research Clinical Trials Network. At Holy Name, he serves on the Patient Safety Committee, the Cancer Committee and the Credentialing Committee. Dr. Rundback earned his medical degree from SUNY Downstate Medical Center, after which he completed his internship at St. Vincent's Hospital and Medical Center, New York, N.Y. He completed his diagnostic radiology residency at Beth Israel Medical Center, New York, N.Y., where he also served as chief resident, and completed his fellowship in interventional radiology at Washington Hospital Center, Washington, D.C. Connect with John 💼 LinkedIn: John H. Rundback, MD About AngioDynamics Established in 1988, as a division of E-Z-EM, AngioDynamics is a company with a rich history that’s defined by its innovation and growth as a committed medical community partner with a focus on developing high-quality medical devices that improve patient outcomes. The company’s commitment to advancing medical solutions has established a strong presence in key healthcare markets worldwide. Through strategic partnerships, distribution networks, and a diverse product portfolio, AngioDynamics continues to contribute to the improvement of patient outcomes on a global scale. AngioDynamics has a notable global presence, with worldwide operations. Learn more about Angiodynamics and the Auryon System 🌐 Websites: angiodynamics.com & auryon-system.com Follow Life of Flow 📲 Instagram: @LifeofFlowPodcast 👍 Facebook: Life of Flow Podcast 💼 LinkedIn: Life of Flow Podcast 🐦 X: @VascularPodcast If this episode gave you a clearer view of BTK care, share it with someone who’d value it. And if you’re enjoying Life of Flow, a quick review helps others find conversations like this!

In this week's episode, we speak with Scott Nelson about the Medicare reimbursement changes that are rapidly reshaping the wound care landscape. Scott explains how cost-plus reimbursement models drove extreme pricing behavior, why CMS intervened, and what the new rules mean for mobile providers, wound care centers, distributors, and manufacturers. This episode focuses on how these changes affect real-world care delivery, market stability, and patient access, not in theory but as it is unfolding right now. 🎧 This episode follows the ongoing conversation around wound care and limb preservation, focusing on how Medicare reimbursement changes are reshaping clinical practice, business models, and decision-making across the industry. 04:43 Scott’s background and entry into medtech and wound care 07:03 Why the wound care market is fragmented and difficult to evaluate 10:02 How skin substitutes became financially distorted under cost-plus reimbursement 11:35 COVID, mobile wound care, and unintended reimbursement incentives 14:21 How pricing mechanics drove extreme markups 23:39 Fraud, abuse cases, and the consequences for the broader market 27:00 What the new reimbursement rules change starting January 35:36 Expected impacts on providers, distributors, manufacturers, and patients 💡 Who Should Listen This episode is for vascular surgeons, wound care clinicians, healthcare operators, MedTech founders, and investors who need a clear understanding of how reimbursement policy directly shapes care models, business viability, and patient outcomes in wound care. About Scott Nelson Scott Nelson currently serves as Vice President of Sales and Marketing at Swift Medical and is a member of the Board of Directors at The Save A Leg, Save A Life Foundation. As the Founder of PrescribedGrowth, Scott advises and consults on emerging technologies on commercial strategy, marketing, sales, and branding. Prior to these roles, Scott worked at LifeNet Health in marketing for wound management and surgical reconstruction, focusing on developing commercial strategies and communications. Scott also held the position of Director of Marketing and Product Solutions at Integer Holdings Corp., where responsibilities included portfolio strategy and market development for the Advanced Surgical & Orthopedic business unit. Scott holds a Bachelor of Science degree in Business Management and Information Systems from the University of Phoenix. Connect with Scott 💼 LinkedIn: Scott Nelson Follow Life of Flow 📲 Instagram: @LifeofFlowPodcast 👍 Facebook: Life of Flow Podcast 💼 LinkedIn: Life of Flow Podcast 🐦 X: @VascularPodcast If this episode helped clarify what’s driving the current shifts in wound care reimbursement, consider sharing it with someone navigating these changes. And if you’re enjoying Life of Flow, leaving a quick review helps more people find these conversations.

Kassidy Warren joins the podcast to share the real estate strategies that helped him move from corporate burnout to financial independence. He explains how high-earning professionals can use leverage, forced appreciation, short-term rentals, cost segregation, and bonus depreciation to reduce taxes and build long-term equity. Kassidy also reflects on the experiences that shaped his path, from van life to rebuilding his career through consulting, and the inner work that led him toward community, mentorship, and purpose. 🎧 This episode goes inside the hard decisions, tax strategies, and mindset shifts that helped Kassidy Warren go from corporate burnout to financial independence, and how high-earning professionals can use real estate, the right tax tools, and a clearer sense of purpose to change their relationship with work and time. 01:04 Kassidy’s corporate path, burnout, and the moment he realized he needed out 02:35 Why he and his wife saved aggressively and left everything to live in a van 04:51 How consulting tripled their income and gave them a path forward 06:06 Buying real estate with a purpose: taxes, equity, and long-term freedom 09:30 The velocity of money explained 10:12 How leverage and forced appreciation multiply wealth 12:34 Depreciation, the short-term rental rules, and why they matter 13:21 How one property can offset years of taxes 19:38 The 1031 exchange and why trading up changes everything 30:33 Breathwork, healing, and the inner work behind Kassidy’s transformation 💡 Who Should Listen This episode is for physicians, high-earning professionals, and anyone interested in real estate, tax strategy, personal growth, or creating more autonomy in their life and work. About Kassidy Kassidy Warren is a real estate investor and coach who helps people buy properties that reduce their tax burden, build equity, and create long-term freedom. He previously worked in engineering and IT before leaving corporate life due to burnout. After living in a van with his wife and rebuilding their careers through consulting, they built a portfolio of short-term rentals. Kassidy now leads a mastermind called Escape Velocity, where he supports members through real estate education, community, and mindset work. Connect with Kassidy 📲 Instagram: @kassidy.warren 💼 LinkedIn: Kassidy Warren 🌐 kassidywarren.com Follow Life of Flow 📲 Instagram: @LifeofFlowPodcast 👍 Facebook: Life of Flow Podcast 💼 LinkedIn: Life of Flow Podcast 🐦 X: @VascularPodcast If this conversation gave you a new perspective on real estate, taxes, freedom, or the choices high-earning professionals actually have, share it with someone who would value it. And if you’ve been enjoying Life of Flow, a short review helps more listeners discover episodes like this one.

En este episodio de Life of Flow Podcast, conversamos con el Dr. Luis Corrales-Rodríguez, oncólogo médico en Costa Rica y uno de los impulsores más importantes del desarrollo de investigación clínica en el país. A través de su experiencia personal construyendo Simca, un centro dedicado exclusivamente a estudios clínicos en oncología, el Dr. Corrales explica cómo se reconstruyó un ecosistema de investigación después de años de prohibición, qué retos encontraron y por qué Latinoamérica necesita estudiar a sus propias poblaciones. Este episodio aborda oportunidades reales para crear valor científico en la región, los vacíos estructurales que aún persisten y la visión de futuro para fortalecer la investigación académica y multinacional en Costa Rica. English Version of the Episode 👉 youtube.com/watch?v=v0mJF1-OKGM 05:48 Falta de infraestructura y personal tras años sin investigación 09:40 Regreso de Luis al país y su decisión de dedicarse a investigación clínica 13:20 Primer estudio abierto tras la nueva ley y el reto de una mutación poco frecuente 17:54 Diferencias genéticas en Latinoamérica y su impacto en cáncer de pulmón 22:47 Por qué Costa Rica solo realiza fases II–IV y la estructura ética involucrada 26:55 Construcción de Simca y crecimiento del centro como sitio de investigación 35:58 Obstáculos iniciales: permisos, educación del público y desconocimiento médico 48:54 Futuro de Simca y la importancia de impulsar investigación académica local 💡¿Quién debería escuchar este episodio? Profesionales de la salud interesados en investigación clínica, líderes de centros médicos, médicos jóvenes que evalúan participar en estudios, y cualquier persona que estudie cómo se construyen ecosistemas de investigación en Latinoamérica. Sobre Dr. Luis Corrales-Rodríguez Luis Corrales-Rodríguez es médico oncólogo en el Hospital San Juan de Dios y en el Centro para la Investigación y Manejo del Cáncer (Simca) en Costa Rica. Realizó su formación en la Universidad de Costa Rica, completó su residencia en Oncología Médica en 2009 y posteriormente un fellowship en oncología torácica en el Hospital Notre-Dame del CHUM en Montreal, Canadá. A su regreso al país, se integró como profesor en la Universidad de Costa Rica y se convirtió en investigador principal de varios estudios internacionales. Es miembro de ACOMED, CLICaP, ASCO, ESMO y IASLC. Sigue a Life of Flow 📲 Instagram: @LifeofFlowPodcast 👍 Facebook: Life of Flow Podcast 💼 LinkedIn: Life of Flow Podcast 🐦 X: @VascularPodcast ¿Conoces a alguien que debería escuchar esta conversación? 🎧 Envíale este episodio y ayúdanos a que más personas accedan a estas historias y aprendizajes.

This week, Neal K. Shah joins the show to talk about the years-long caregiving journey that reshaped his life, his career, and ultimately the creation of CareYaya Health Technologies. He shares how managing a billion-dollar hedge fund became incompatible with the reality of his grandfather’s dementia care and his wife’s life-threatening illness, and how those experiences exposed the true weight carried by family caregivers. 🎧 This episode traces Neal Shah’s shift from hedge fund leader to full-time caregiver and founder of CareYaya. He shares what the home-care system really looks like for families and how a tech-enabled student workforce is changing access to reliable support. 04:52 Early hedge fund career and the shift triggered by family illness 07:50 The cost, quality gaps, and hidden burdens families face 10:49 Recognizing the scale of unmet needs for aging and chronic illness 18:54 The idea that became CareYaya: a structured way to connect families with healthcare-bound students 21:35 Building the MVP with local universities and early explosive demand 25:04 How finding the right technical co-founder shaped the company’s trajectory 28:36 How new ideas emerged, including AI tools for claims management 32:20 Why younger engineers outperform in an AI-first world 40:35 Could Medicare eventually reimburse companion-level care? 41:20 How this could scale into a multibillion-dollar platform 44:49 The political torque keeping insurance reform stagnant 💡 Who Should Listen Healthcare innovators, MedTech founders, clinicians who support aging or chronically ill populations, caregivers, and anyone building technology to solve real structural problems in the healthcare system. About Neal Neal K. Shah is the CEO of CareYaya Health Technologies, a social enterprise and research lab advancing health equity for aging populations, and recognized by LinkedIn as one of America’s Top 50 Startups in 2024. He also serves as Chairman of Counterforce Health, an AI platform for navigating health insurance claim denials, and Principal Investigator on multiple federal innovation grants. Shah is also the author of “Insured to Death: How Health Insurance Screws Over Americans - And How We Take It Back”, a #1 bestseller in Health Policy. Shah holds degrees in economics and philosophy from University of Pennsylvania. Prior to CareYaya, Shah managed a $250 million hedge fund. His pivot to healthcare came after deeply personal experiences as a caregiver, which inspired a mission-driven focus on transforming care delivery through tech. Today, Shah is building CareYaya into a national leader in care innovation. Shah’s work has been supported by the NIH, Johns Hopkins AITC, AARP, and Harvard Innovation Labs. He also regularly contributes to CNBC, US News & World Report, Barron’s, STAT, Neurology Live, and Medical Economics. Connect with Neal 💼 LinkedIn: Neal K. Shah 📲 Instagram: @nealkshah 🎶 TikTok: @nealkshah 📘Substack: nealkshah.substack.com 💼 LinkedIn: Counterforce Health 📲 Instagram: @counterforcehealth 🎶 TikTok: @counterforcehealth About CareYaya Health Technologies CareYaya is a mission-driven social enterprise supported by dozens of interns and volunteers nationwide. This provides affordable care for thousands of families, introduces tens of thousands of energetic individuals into the care workforce, and impacts millions by investing in the healthcare professionals of tomorrow. Together, they’re changing elder care by connecting families with compassionate, motivated college students from top universities. Learn more about CareYaya 🌐 Website: careyaya.org 💼 LinkedIn: @Careyaya 📲 Instagram: @wearecareyaya 🎶 TikTok: @wearecareyaya Follow Life of Flow 📲 Instagram: @LifeofFlowPodcast 👍 Facebook: Life of Flow Podcast 💼 LinkedIn: Life of Flow Podcast 🐦 X: @VascularPodcast If this episode gave you a new take on caregiving or the gaps in home care, share it with someone who’d value it. And if you’re enjoying Life of Flow, a quick review helps others find conversations like this!

En este episodio de Life of Flow Podcast, conversamos con el Dr. Pedro G. R. Teixeira, M.D., cirujano vascular y de trauma en UT Health Austin y Ascension Seton. Juntos exploramos su recorrido desde Belo Horizonte hasta liderar una división académica en Austin, y cómo esa trayectoria marcó su visión sobre formación, adaptabilidad, trabajo en equipo y liderazgo quirúrgico. ❗️Este episodio, grabado originalmente en inglés y ahora doblado al español, captura una conversación honesta sobre liderazgo médico, trabajo interdisciplinario y el futuro de la atención basada en valor. English Version of the Episode 👉youtube.com/watch?v=x5Jl0FEmnqQ 01:05 Nacer y formarse en Belo Horizonte: primeros pasos en trauma 04:00 Llegar a EE. UU. como adjunto y descubrir un sistema quirúrgico completamente distinto 07:10 Repetir la residencia desde cero: humildad, ego y aprendizaje 10:15 Barreras culturales: acrónimos, lenguaje quirúrgico y reinvención diaria 13:40 El valor real del cirujano más allá del título y la jerarquía 18:00 Descubrir la cirugía vascular y la emoción de volver a ser principiante 21:05 Por qué mantiene guardias de trauma: compromiso social y responsabilidad 24:00 El cirujano vascular como soporte esencial en casos complejos 33:05 El proceso inesperado de convertirse en jefe de división 37:00 Su visión para transformar la atención vascular en Austin y construir una cultura colaborativa 💡¿Quién debería escuchar este episodio? Médicos en formación, cirujanos vasculares y de trauma, líderes clínicos, profesionales internacionales interesados en entrenar en EE. UU. y cualquier persona que trabaje en estructuras académicas o equipos quirúrgicos de alto rendimiento. Sobre Dr. Pedro G. R. Teixeira, MD Pedro G. R. Teixeira, MD, es un cirujano vascular certificado que ejerce en el Institute for Cardiovascular Health, una colaboración entre Ascension y UT Health Austin. Está especializado en el manejo integral de enfermedades arteriales y venosas, y colabora con múltiples especialidades quirúrgicas en procedimientos complejos que requieren exposición y reconstrucción vascular. Es profesor en el Departamento de Cirugía Cardiovascular y Torácica de Dell Medical School en la Universidad de Texas en Austin. Se formó inicialmente en Brasil y completó residencia en cirugía general, una beca en cirugía vascular y otra en cuidados críticos quirúrgicos en la Universidad del Sur de California. Su investigación se centra en el cruce entre trauma y cirugía vascular, con más de 150 publicaciones revisadas por pares, y ha contribuido de manera decisiva a la educación quirúrgica y al desarrollo de principios modernos de control de hemorragias y técnicas mínimamente invasivas. Es coeditor de Vascular Injury: Endovascular and Open Surgical Management, presidente de la Texas Society for Vascular and Endovascular Surgery y miembro activo de múltiples organizaciones quirúrgicas nacionales e internacionales. 🌐 UT Health Austin: Pedro G. R. Teixeira, MD Sigue a Life of Flow 📲 Instagram: @LifeofFlowPodcast 👍 Facebook: Life of Flow Podcast 💼 LinkedIn: Life of Flow Podcast 🐦 X: @VascularPodcast ¿Conoces a alguien que debería escuchar esta conversación? 🎧 Envíale este episodio y ayúdanos a que más personas accedan a estas historias y aprendizajes.

In this episode, we sit down with Shane Gleason, Chief Commercial Officer at InspireMD, to talk about what it means to bring a new carotid stent to market at a time when treatment options are evolving. Shane shares how his two decades in the vascular space shaped the way he evaluates timing, team, and technology, and why those factors mattered when he decided to join InspireMD. He also walks through the details of their flexible open-celled nitinol stent with a finely woven PET mesh, explaining what it does, how it behaves, and why physicians have responded so strongly to it. The conversation moves from device design to clinical trials, commercial planning, and the changing landscape following CMS’s expanded coverage for carotid stenting. 🎧 This episode goes inside the work behind developing and launching a new carotid stent, and how the right timing, the right team, and a device designed for lasting protection can shift practice. 04:50 Why carotid procedures still make him sweat after hundreds of cases 06:14 What lasting protection means and why post-procedure events matter 07:01 Dual antiplatelet therapy and how the PET mesh behaves in the vessel 07:33 Showing the stent on camera and explaining the woven PET mesh 08:36 TCAR, transfemoral approaches, and what current trials are studying 11:12 How Shane’s team is approaching commercialization in the U.S. 12:22 Why the procedure attracts experienced reps and how they support cases 14:17 Why physicians say they’ve “been waiting for this for 20 years” 16:02 What it means to be the only company singularly focused on carotid disease 💡 Who Should Listen This episode is for vascular surgeons, neurointerventionalists, industry professionals supporting carotid interventions, and anyone following the current shift in carotid disease treatment and device innovation. About Shane Mr. Gleason has over 20 years of experience in the medical device industry leading clinical and commercial operations in both public and privately held companies. Prior to joining InspireMD, he served as Vice President of Sales, Vascular Interventions at Surmodics, a medical device company focused on addressing unmet clinical needs in intravascular medicine. Prior to Surmodics, Mr. Gleason served in a variety of leadership roles in the interventional medical device space, to include Senior Director, US Transcatheter Heart Valves Marketing for Edwards Lifesciences, a developer of artificial heart valve technologies; Chief Commercial Officer of Nuvaira, a privately held developer of therapies that preserve patient lung health; and Vice President of Sales roles with both Cordis, a Cardinal Health company, and TriVascular Technologies, now part of Endologix. He began his medical device career with a variety of progressive leadership roles at Abbott Vascular, where he launched the second FDA approved carotid stent system. Mr. Gleason received his B.S. in Engineering Science and Mechanics from Virginia Polytechnic Institute and State University and his M.B.A. from the University of Maryland’s Smith School of Business. Connect with Shane 💼 LinkedIn: Shane Gleason 🌐 InspireMD: inspiremd.com/team/shane-gleason/ About InspireMD InspireMD is a global carotid-focused company dedicated to helping prevent stroke, save lives, and give physicians and patients the confidence to choose carotid stenting without compromise. Based in Miami, the company is leading an international effort to advance carotid artery intervention through thoughtful engineering and a commitment to innovation. Their mission centers on one idea: stroke prevention is the blueprint, not an afterthought. With a focus on smarter design and strong clinical data, InspireMD aims to protect against carotid plaque prolapse and support physicians with a solution built for safety and clarity. CGuard® Prime, the company’s flagship product, is a next-generation carotid stent featuring a dual-layer design with a finely woven MicroNet™ mesh. It is the only FDA-approved mesh-covered carotid stent and was designed to offer a new layer of defense against the risk of plaque prolapse and embolization. In pivotal studies, CGuard Prime demonstrated the lowest independently adjudicated 30-day and 1-year major adverse event rates reported to date. Learn more about InspireMD 🌐 Website: inspiremd.com/ Follow Life of Flow 📲 Instagram: @LifeofFlowPodcast 👍 Facebook: Life of Flow Podcast 💼 LinkedIn: Life of Flow Podcast 🐦 X: @VascularPodcast If this episode gave you a new perspective on carotid disease treatment, device innovation, or the future of carotid stenting, share it with a colleague who would value the conversation. And if you’ve been enjoying Life of Flow, leaving a short review helps more listeners find stories like this one.

En este episodio de Life of Flow Podcast, conversamos con el Dr. Dimitrios Miserlis, M.D., profesor asistente de cirugía vascular en UT Dell y cirujano vascular en Ascension Seton, Austin. El Dr. Miserlis comparte su mirada sobre cómo la inteligencia artificial está transformando la práctica médica, desde los diagnósticos por imagen hasta la robótica quirúrgica. A lo largo de la charla, reflexiona junto a Lucas Ferrer y Miguel Montero-Baker sobre el equilibrio entre ciencia, filosofía y propósito humano en la evolución tecnológica. ❗️Este episodio, grabado originalmente en inglés y ahora doblado al español, captura una conversación honesta sobre liderazgo médico, trabajo interdisciplinario y el futuro de la atención basada en valor. English Version of the Episode 👉youtube.com/watch?v=FiJY_AtEEYg 02:00 Orígenes en Grecia y el camino hacia la medicina en EE. UU. 05:00 Primeros pasos en investigación y llegada a Texas 07:00 Cómo el entorno y las personas impulsan la innovación 10:00 De qué hablamos realmente cuando hablamos de inteligencia artificial 12:00 El test de Turing y los pilares de la IA moderna 15:00 Aplicaciones médicas: de la radiología a los sistemas diagnósticos 18:00 Los límites de la IA: imaginación, intuición y creatividad 22:00 Robótica blanda y medicina inclusiva 26:00 Riesgos, control y el desafío de comprender los algoritmos 31:00 Comunicación entre científicos y propósito en la innovación médica 💡¿Quién debería escuchar este episodio? Profesionales de la salud, investigadores y emprendedores del ámbito médico-tecnológico interesados en entender cómo la inteligencia artificial y la robótica están redefiniendo la práctica clínica y los desafíos éticos que esto plantea. Sobre Dr. Miserlis, MD Dimitrios Miserlis, MD, es un cirujano vascular con certificación de especialidad en Ascension Seton (Austin y Bastrop, Texas). Está especializado en flebología y en la evaluación y el tratamiento integral de las enfermedades venosas. Como experto en el sistema vascular, está altamente capacitado para tratar todo tipo de patologías de los vasos sanguíneos. Cada consulta con el Dr. Miserlis comienza con una conversación: dedica el tiempo necesario para responder todas las preguntas, grandes o pequeñas. 🌐 Ascension: healthcare.ascension.org/find-care/provider/1720375348/dimitrios-miserlis Sigue a Life of Flow 📲 Instagram: @LifeofFlowPodcast 👍 Facebook: Life of Flow Podcast 💼 LinkedIn: Life of Flow Podcast 🐦 X: @VascularPodcast ¿Conoces a alguien que debería escuchar esta conversación? 🎧 Envíale este episodio y ayúdanos a que más personas accedan a estas historias y aprendizajes.

In this episode of the Life of Flow Podcast, we talk with Mathias Ihlenfeld, an Austin-based entrepreneur, coach, and founder of Woom Bikes USA. Mathias shares how he went from landing in the U.S. with a tennis racket and a dream to building one of the country’s leading children’s bike brands. He reflects on what it takes to start over, listen to change when it calls, and channel energy into building something that lasts. 🎧 This episode dives into the work behind reinvention. How clarity, conviction, and persistence can turn a single idea into a purpose-driven business that grows with heart. 02:00 From Frankfurt to Louisiana: finding home in a new country 04:55 How moving between U.S. states felt like crossing countries 08:30 The power of reinvention and why resilience matters 11:20 From corporate consulting to founding Woom 14:35 The subtle (and not-so-subtle) signs it’s time to change course 16:50 The “hero’s journey” and how it shows up in real life 22:05 From selling 13 bikes to leading a multimillion-dollar company 23:40 Creating a brand that connects with families everywhere 25:10 Energy, focus, and passion: what drives sustainable growth 28:38 Balancing two careers, family, and the long view of success 💡 Who Should Listen For founders, builders, and anyone standing at a crossroads. This episode speaks to those who want to grow with purpose and are ready to rebuild their next chapter with intention. About Mathias Mathias Ihlenfeld is an award-winning entrepreneur, the Austin, TX Cohort Leader and Coach for the Birthing of Giants Regional Cohort, a selective fellowship program for growth-focused founders and CEOs building high-impact companies. He is also the creator of The R.E.C.L.A.I.M. Code (Elite Personal Optimization Framework for divorced high performers). His proprietary 6-stage framework helps divorced founders rebuild identity, attract aligned love, and ignite purpose-driven business performance. As the founder of Woom Bikes USA, Mathias built one of North America’s fastest-growing direct-to-consumer kids’ bike companies, earning multiple Inc. 5000 honors, including a 742% three-year growth rate in 2020, and recognition as one of the fastest-growing private companies in the U.S. In 2021, he played a pivotal role in merging the U.S. and European operations, leading the combined $100M global business as CEO in 2022 and 2023. His leadership has been recognized with honors such as Ernst & Young Entrepreneur of the Year finalist and the Vistage Impact Leadership Award. Through his coaching practice, he works with founders, executives, and high-achieving men navigating personal reinvention, guiding them through identity rebuilding, emotional mastery, business growth, and relationship alignment. Today, Mathias mentors with SKU, invests in purpose-driven brands, and writes on his Substack, sharing hard-earned lessons, strategic insight, and stories from his journey building global brands and leading life transformations. Connect with Mathias 📲 Instagram: @sundaygog 💼 LinkedIn: Mathias Ihlenfeld 🌐 MentorPass: mentorpass.co/mathiasihlenfeld Follow Life of Flow 📲 Instagram: @LifeofFlowPodcast 👍 Facebook: Life of Flow Podcast 💼 LinkedIn: Life of Flow Podcast 🐦 X: @VascularPodcast If this episode shifted your view on entrepreneurship, leadership, or starting over, share it with someone who would value the conversation. And if you’ve been enjoying Life of Flow, leaving a short review helps more listeners find stories like this one.

En este episodio de Life of Flow Podcast, conversamos con David G. Armstrong, DPM, PhD, profesor distinguido de Cirugía y Neurocirugía en la Universidad del Sur de California (USC) y cofundador de la Southwestern Academic Limb Salvage Alliance (SALSA). A través de anécdotas personales y reflexiones profundas, el Dr. Armstrong comparte cómo una herida aparentemente pequeña cambió el rumbo de su carrera y lo llevó a dedicar su vida a la preservación de extremidades y a lo que él llama “tratar la ausencia de síntomas”. Exploramos la evolución de los programas modernos de salvamento de extremidades, la creación de equipos multidisciplinarios y el impacto de la colaboración entre podología y cirugía vascular en todo el mundo. ❗️Este episodio, grabado originalmente en inglés y ahora doblado al español, captura una conversación honesta sobre liderazgo médico, trabajo interdisciplinario y el futuro de la atención basada en valor. English Version of the Episode 👉 youtube.com/watch?v=gK5Aqw4_5Qw 04:07 Infancia, familia y la vocación por devolver lo recibido 05:31 El “don del dolor” y su encuentro con una paciente con lepra y diabetes 09:00 Cómo un momento marcó el inicio de su trayectoria en la preservación de extremidades 10:00 El salto de Detroit a San Antonio y el comienzo de una nueva etapa 11:14 Mentores, aprendizaje y los primeros años de investigación clínica 13:07 La decisión de seguir su propio camino y las lecciones familiares 14:11 La creación de los primeros programas integrados en Texas y Arizona 17:06 El nacimiento de una alianza entre podología y cirugía vascular 19:37 Qué define a un programa moderno de preservación de extremidades 24:17 Centros de excelencia y atención basada en valor: el futuro del cuidado vascular 27:55 El “hotline” de cuatro pasos: una guía práctica para equipos multidisciplinarios 💡¿Quién debería escuchar este episodio? Profesionales de la salud interesados en la atención integral del pie diabético, cirujanos vasculares, podólogos, líderes de programas hospitalarios y médicos que buscan implementar modelos colaborativos para reducir amputaciones y mejorar resultados clínicos. Sobre Dr. Armstrong Dr. David G. Armstrong, DPM, PhD ha publicado más de 720 artículos científicos revisados por pares y más de 120 libros o capítulos de libro. Es Director del Center to Stream Healthcare in Place (C2SHiP), un centro financiado por la National Science Foundation (NSF) que busca integrar tecnología, dispositivos médicos y wearables para maximizar los días activos y libres de hospitalización. Reconocido mundialmente como pionero en la prevención de amputaciones, el Dr. Armstrong es fundador y presidente de la American Limb Preservation Society (ALPS) y cofundador de la International Diabetic Foot Conference (DF-Con), el simposio más grande del mundo dedicado al pie diabético. 📲 Instagram: @d.g.armstrong Sigue a Life of Flow 📲 Instagram: @LifeofFlowPodcast 👍 Facebook: Life of Flow Podcast 💼 LinkedIn: Life of Flow Podcast 🐦 X: @VascularPodcast ¿Conoces a alguien que debería escuchar esta conversación? 🎧 Envíale este episodio y ayúdanos a que más personas accedan a estas historias y aprendizajes.